Details of CPPsite entry with Sequence GLKKLAELAHKLLKLG |
| Primary information | |
|---|---|
| PEPTIDE SEQUENCE | GLKKLAELAHKLLKLG |
| CPPsite ID | 2793, 2795, |
| PEPTIDE NAME | Peptide 2C- GNS, Peptide 2N- GNS |
| CHIRALITY | L, L |
| LINEAR/CYCLIC | Linear, Linear |
| SOURCE | Synthetic, Synthetic |
| CATEGORY | NA, NA |
| SUB CELLULAR LOCALIZATION | NA, NA |
| N-TERMINAL MODIFICATION | Free, Conjugated to nanoparticles |
| C-TERMINAL MODIFICATION | Conjugation with nanoparticle, Amidation |
| CHEMICAL MODIFICATION | NA, NA |
| UPTAKE EFFICIENCY | NA, NA |
| PROPOSED UPTAKE MECHANISM | NA, NA |
| INVITRO/INVIVO | In vitro, In vitro |
| CELL LINE | HeLa, A549 and 3T3-L1 cells, HeLa, A549 and 3T3-L1 cells |
| In VIVO MODEL | NA, NA |
| CARGO | Nanoparticle (Gold), Nanoparticle (Gold) |
| PMID | 23545289, 23545289 |
| PATENT | Unknown, Unknown |
| Tertiary Structure (Technique) | 2793 (PEPstrMOD), 2795 (PEPstrMOD), |